Fig. 9
From: Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
LN-targeting nanoplatforms based on the immune cell membrane. A Schematic representation of the preparation and antitumor immune induction of Man-RBC-NPhgp (Adapted with permission from [135]. Copyright © 2015, American Chemical Society) B Illustration of the synthesis and anti-tumor mechanism of DCM/HCtSA/OVA. (Adapted with permission from [130]. Copyright © 2020, American Chemical Society) C Fabrication process of MOF@FM. D MOF@FM inoculation for tumor prevention E Mechanisms of MOF@FM targeting LNs (Adapted with permission from [131]. Copyright © 2019, Wen-Long Liu et al., Nature Communications.)